Welm et al. assessed microarray gene data of 295 breast cancer patients from the Netherlands Cancer Institute and noted decreased time to metastasis and decreased overall survival in patients with concomitant overexpression of RON, MSP, and MT-SP1. This evidence concerns the gene MST1R and breast cancer.